Compare APAM & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APAM | PAHC |
|---|---|---|
| Founded | 1994 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2011 | 2014 |
| Metric | APAM | PAHC |
|---|---|---|
| Price | $36.75 | $57.78 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $44.40 | $34.33 |
| AVG Volume (30 Days) | ★ 741.1K | 275.6K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 10.45% | 0.81% |
| EPS Growth | 10.66 | ★ 1883.33 |
| EPS | ★ 4.05 | 1.32 |
| Revenue | ★ $1,196,688,000.00 | $833,350,000.00 |
| Revenue This Year | $7.55 | $17.03 |
| Revenue Next Year | $5.21 | $3.82 |
| P/E Ratio | ★ $9.15 | $44.80 |
| Revenue Growth | ★ 7.63 | 4.12 |
| 52 Week Low | $33.88 | $16.16 |
| 52 Week High | $48.46 | $59.68 |
| Indicator | APAM | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 47.56 | 61.55 |
| Support Level | $35.01 | $37.09 |
| Resistance Level | $45.09 | N/A |
| Average True Range (ATR) | 0.96 | 2.64 |
| MACD | 0.33 | 0.26 |
| Stochastic Oscillator | 84.19 | 74.94 |
Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. The company operates as one segment in the investment management business. The company generates maximum portion of its revenues from clients domiciled in countries outside the United States.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.